11，Alderman ML，Budner N，ColenH，et al．Prevalence of drug resistance h ypertension．Hypertension，1988，11（suppl）：11
22，Menard J．Improving hypertension treatment．What should we put our e fforts．Newdrug，new concept，or new management？Am J Hypertens，1992，5（2 ）：252
33，Yakovlevitch M，Black HR．Resista nt hypertension in a tertiary care clinic．ArchIntern Med，1991，15（6）： 1786
44，Guyton AC．Kidneys and fluids in pressure regulation．Smallvolume o ut large pressure changes．Hypertens ion，1992，19（suppl）：2
55，Kelly RA，Wilcox CS，Mitch WE，et al．Response of the kidney to furos emide．Effectof captopril on sodiu m baance．Kidney Int，1983，24（2）：233
66，Sleight P．Smoking and hypertensi on．Clin Exp Hypertens，
71993,15（9）：1181
87，Isaksson H，Cederholm T，Jansson E，et al．Therapy resistant hyperten sionassociated with central obesi ty，insulin resistance，and large mu scle fibre area．BloodPressure，199 3，2（1）：46
3Chobanian AV,Bakris OI. The seventh report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure: the JNC7 report [J]. JAMA, 2003, 289:2560-2572.
4Brown MJ,Cruickshank JK, Dominiczak AF,el al. Executive committee, British Hypertensiotl Society, Better blood pressure control :how to combine drug[J]. J Hum Hypertens ,2003,17:81-86.
5Menard J. Improving hypertension treatment. Where should we put our efforts: new drugs, new concepts, or new management [J]? Am J Hypertens, 1992, 5 (12 Pt 2): 252S-258S.
6Parker Jo. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris[J]. Am J cardiol, 1993, 72 (12): 871-816.
